GOTHENBURG, Sweden/ SAN FRANCISCO, CA, September 11, 2018
Heliospectra AB (publ) (OTCQB: HLSPY, FIRST NORTH: HELIO), a world leader in intelligent lighting technology for greenhouse and controlled plant growth environments, announces a new order from Danish company Cannabis Pharm. The company is setting a new high-tech production facility in Randers, Denmark and has chosen Heliospectra's fully adjustable ELIXIA LED lighting solutions and market-leading HelioCORE™ light control software to fully automate their lighting environment and provide highest quality pharmaceutical products. The order value is SEK 1.4 million (USD $ 154,000).
Cannabis Pharm is building a new high-density vertical cultivation system in Randers, Denmark. The cultivation team has partnered with Heliospectra and their Canadian partner Montel, combining centralized LED light management strategies and state-of-the-art mobile racks for a total solution to optimize plant quality and maximize production and business performance.
Production of highest-quality crops and the ability to control medicinal profiles is of utmost importance when supplying patients with pharmaceutical-grade, safe products. We believe full control, automation and the ability to standardize harvest results is key to reach these goals. Further, a flexible lighting solution allows us to continue to optimize and conduct research to further strengthen our product portfolio and understanding of this versatile crop." said Morten Mortensen, CEO and Owner Cannabis Pharm.
"Denmark is quickly becoming one of Europe's biggest medical cannabis producers. As the European market continues to expand the medical cannabis industry, standardized high-quality products are key to success. During its' life cycle, the cannabis plant goes through several different growth stages, all with different requirements on environmental factors such as light levels and spectrum. Our intelligent ELIXIA LED grow light solution and helioCORE control software provide growers with the ability to automatically adjust the light with respect to the plants' needs, as well as the environmental prerequisites, thereby optimizing the growing condition for the crop and increases the energy efficiency of the growth", said Ali Ahmadian, CEO Heliospectra.
The quick legislation around the world has created a drive for expertise within the field. We are excited to work together with Cannabis Pharm to increase awareness and expand the knowledge within the industry," he continues.
The ELIXIA light creates clear business benefits for cultivation teams and researchers around the world. The fully adjustable LED lighting solution will be combined with Heliospectra's HelioCORE light control software to ensure that indoor crops receive perfect light 365 days a year.HelioCORE offers advanced controls and flexible light intensities to apply customized lighting schedules with real-time monitoring across the plant growth cycle. The integrated solution improves the quality of plants and accelerates harvest and production cycles while providing consistent and standardized returns.
Delivery will take place during the first quarter of 2019 and be visible in the accounts during the fourth quarter of 2018 and first quarter of 2019.
Ali Ahmadian, CEO of Heliospectra | +46 (0)72 203 6344 | [email protected]
Redeye is Heliospectra Certified Advisor for Nasdaq First North - www.redeye.se
Heliospectra AB (publ) (OTCQB: HLS, FIRST NORTH: HELIO) is the global leader in intelligent lighting technology, light control systems and related services for greenhouse and controlled plant growth environments. With the vision to make commercial crop production more connected and resource-efficient, Heliospectra integrates customized LED spectral strategies with real-time response and artificial intelligence to create predictable and reliable business forecasts and harvest results. Founded in 2006, Heliospectra is committed to helping growers and commercial producers across six continents consistently increase yields and produce crops with quality appearance, superior nutritional or medicinal value and longer shelf life, harvest after harvest. Heliospectra is the recipient of multiple international awards and recognitions. For more information, please visit https://www.heliospectra.com.
The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.
This information is information that Heliospectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14:40 CEST / 7 :40AM CDT on September 11 2018.